GH Carp

Growth Hormone Carp Recombinant
Shipped with Ice Packs
In Stock

Description

Growth Hormone Carp Recombinant produced in E.Coli is a single, non-glycosylated, polypeptide chain containing 188 amino acids & having a molecular mass of 21,408 Dalton.
Growth Hormone Carp is purified by proprietary chromatographic techniques.

Product Specs

Introduction
Growth Hormone (GH) is part of the somatotropin/prolactin hormone family, crucial for growth regulation. The GH gene, along with four related genes, resides on chromosome 17 at the growth hormone locus. Their arrangement, thought to be a result of gene duplications, shows them in the same transcriptional orientation. These five genes share significant sequence similarity. Adding complexity, alternative splicing creates additional isoforms of each growth hormone, increasing diversity and potential specialization. While expressed in the pituitary gland, this specific family member is not found in placental tissue, unlike the other four genes at the growth hormone locus. Mutations or deletions within this gene can lead to growth hormone deficiency and consequently, short stature.
Description
Recombinant Carp Growth Hormone, produced in E. coli, is a single, non-glycosylated polypeptide chain. It consists of 188 amino acids, resulting in a molecular weight of 21,408 Daltons. The purification of Carp Growth Hormone is achieved using proprietary chromatographic methods.
Physical Appearance
Sterile Filtered White lyophilized (freeze-dried) powder.
Formulation
The Carp GH was lyophilized from a concentrated (1mg/ml) solution with 0.3% NaHCO3, adjusted to a pH of 8.
Solubility
For reconstitution of the lyophilized Carp Growth Hormone, it is recommended to use sterile 18MΩ-cm H2O at a concentration not less than 100µg/ml. This solution can be further diluted into other aqueous solutions as needed.
Stability
Lyophilized Carp Growth Hormone remains stable at room temperature for up to 3 weeks. However, for long-term storage, it is recommended to store it desiccated at a temperature below -18°C. After reconstitution, Carp Growth Hormone should be stored at 4°C for 2-7 days. For future use, store below -18°C. The addition of a carrier protein (0.1% HSA or BSA) is advised for extended storage. Avoid repeated freeze-thaw cycles.
Purity
Purity exceeds 95.0% as determined by: (a) Size Exclusion Chromatography-High Performance Liquid Chromatography (SEC-HPLC) analysis. (b) Sodium Dodecyl Sulfate-Polyacrylamide Gel Electrophoresis (SDS-PAGE) analysis.
Biological Activity
Carp GH exhibits biological activity in rat 3T3 F442A preadipocytes. However, it is 15-fold less potent compared to bovine GH. Conversely, it demonstrates equal potency in vivo for promoting carp growth (Fine et al., 1993). Additionally, carp GH forms a 1:2 complex with the extracellular domain of the ovine growth hormone receptor.
Synonyms
GH1, GH, GHN, GH-N, hGH-N,Pituitary growth hormone, Growth hormone 1, Somatotropin.
Source
Escherichia Coli.
Amino Acid Sequence
The sequence of the first five N-terminal amino acids was determined and found to be Ser-Asp-Asn-Gln-Arg.

Q&A

What are GH-transgenic carp and how are they developed for research purposes?

GH-transgenic carp (Cyprinus carpio L.) are common carp that have been genetically engineered to consistently and stably overexpress exogenous growth hormone (GH) genes. These transgenic models are typically developed through microinjection of growth hormone gene constructs into fertilized fish eggs, followed by screening for stable integration and expression.

The transgenic carp exhibit higher serum GH levels and increased expression of GH in various tissues compared to wild-type counterparts . When establishing experimental cohorts, researchers typically hatch transgenic and wild-type carp fry on the same day to ensure proper age-matching and initially raise them on standard commercial aquafeed (typically containing approximately 33% protein, 6% fat, and 22% carbohydrate) before transitioning to experimental diets .

For controlled experiments, juvenile fish are commonly transferred to indoor recirculating aquaculture systems at approximately 2 months of age, where environmental parameters can be precisely maintained, facilitating more accurate assessment of physiological differences between transgenic and wild-type models .

How do researchers distinguish between basic and advanced phenotypic changes in GH-transgenic carp?

Researchers typically categorize phenotypic changes in GH-transgenic carp through a systematic analysis framework:

Basic phenotypic assessments include:

  • Growth rate measurements (body weight, length)

  • Feed conversion efficiency

  • Anatomical development indices (e.g., intestinal somatic index)

  • Baseline metabolic parameters (blood glucose, insulin levels)

Advanced phenotypic analyses incorporate:

  • Molecular profiling (gene expression patterns)

  • Hormone level quantification via ELISA (estradiol, IGF1, IGF2)

  • Pathway-specific evaluations (neuroendocrine signaling)

  • Tissue-specific functional analyses

To systematically distinguish between phenotypic changes, researchers typically sample transgenic and wild-type carp at standardized developmental timepoints (45, 75, 105, 135, 165, and 195 days post fertilization) to generate comprehensive developmental profiles . This temporal approach enables identification of when significant phenotypic divergence occurs - for instance, intestinal weight differences between transgenic and wild-type carp become significant only after 165 days post fertilization despite no differences in intestinal somatic index (ISI) .

What fundamental experimental design considerations apply when studying GH-transgenic carp?

When designing experiments involving GH-transgenic carp, researchers should implement several critical methodological approaches:

  • Standardized fasting protocols: Different experimental measurements require specific fasting durations:

    • Gene expression analyses typically require 6-hour fasting periods (based on peak expression patterns)

    • Enzyme activity assessments also utilize 6-hour fasting periods

    • Morphological and histological analyses require 48-hour fasting to ensure empty intestinal tracts

    • Baseline metabolic measurements typically employ overnight fasting

  • Tissue-specific sampling strategies: For comprehensive analyses, researchers should employ region-specific sampling of the intestinal tract:

    • Foregut samples should be collected 0.3-0.5 cm before the first intestinal fold

    • Midgut samples from the middle section of the intestine

    • Hindgut samples 0.3-0.5 cm after the last intestinal fold

  • Statistical analytical approaches: Proper statistical methods must be employed:

    • Independent t-tests for comparing transgenic vs. wild-type fish on the same diet

    • One-way ANOVA followed by Tukey's HSD for glucose tolerance test (GTT) data

    • Two-way ANOVA to determine interaction effects between GH levels and dietary treatments

How does GH overexpression mechanistically disrupt reproductive development in transgenic carp?

GH overexpression disrupts reproductive development in transgenic carp through multiple coordinated molecular mechanisms operating across the hypothalamic-pituitary-gonadal (HPG) axis:

  • Direct pituitary effects: GH exerts paracrine inhibitory effects on gonadotropin production where:

    • Elevated GH suppresses pituitary luteinizing hormone (LH) content and serum LH levels

    • GH inhibits expression of gonadotropin subunit genes (gthα, fshβ, and lhβ)

    • Western blotting confirms reduced pituitary Gh, Lhβ, and Gthα subunit levels in GH-transgenic carp

  • Gonadotropin-releasing hormone (GnRH) receptor modulation: While gnrh3 expression remains unchanged, gnrhr2 (the receptor mediating GnRH3 effects) shows significantly decreased expression in the pituitary of transgenic carp, contributing to reduced gonadotropin production and pituitary sensitivity to GnRH .

  • Dopaminergic system upregulation: RNA sequencing and targeted PCR confirm increased expression of dopamine receptors:

    • drd1 (dopamine receptor D1)

    • drd3 (dopamine receptor D3)

    • drd4 (dopamine receptor D4)

    This dopaminergic upregulation further contributes to reproductive inhibition in transgenic fish .

  • Gonadal steroidogenesis inhibition: GH overexpression leads to:

    • Decreased serum estradiol levels specifically in female GH-transgenic carp

    • Reduced expression of cyp19a1a (aromatase A) in the gonads, a key enzyme in estradiol synthesis

    • Decreased expression of cyp19a1b (aromatase B) in the hypothalamus

These molecular mechanisms collectively explain the delayed reproductive development observed in GH-transgenic carp, providing researchers with multiple intervention points for experimental manipulation.

What methodological approaches effectively measure neuroendocrine disruption in GH-transgenic carp?

Researchers employ several complementary methodological approaches to comprehensively evaluate neuroendocrine disruption in GH-transgenic carp:

  • Serum hormone quantification:

    • ELISA for measuring GH, estradiol, IGF1, and IGF2 levels

    • Radioimmunoassay (RIA) for select hormones requiring higher sensitivity

    • Statistical significance typically set at P < 0.05

  • Gene expression profiling:

    • RNA sequencing for genome-wide expression analysis

    • Targeted PCR confirmation of key neuroendocrine genes including:

      • Gonadotropin subunits (gthα, fshβ, lhβ)

      • GnRH receptors (gnrhr1, gnrhr2, gnrhr3, gnrhr4)

      • Dopamine receptors (drd1, drd3, drd4)

      • Aromatase genes (cyp19a1a, cyp19a1b)

  • Protein quantification:

    • Western blotting for pituitary protein levels (Gh, Lhβ, Gthα, Prl)

    • Fluorescence in situ hybridization for receptor localization (e.g., leptin receptor in pituitary regions)

  • Functional assays:

    • In vitro incubation of pituitary tissues to assess hormone responsiveness

    • Recombinant protein stimulation (e.g., carp Leptin) to evaluate:

      • Pituitary gthα, fshβ, lhβ expression

      • Ovarian germinal vesicle breakdown

These methodological approaches provide researchers with a comprehensive toolkit for investigating the complex neuroendocrine disruptions in GH-transgenic carp, enabling mechanistic insights beyond simple correlation.

How do metabolic alterations induced by GH overexpression contribute to reproductive disruption?

GH overexpression induces significant metabolic alterations that contribute to reproductive disruption through several interconnected pathways:

  • Energy status signaling disruption:

    • Lower expression of gys (glycogen synthase) and reduced hepatic glycogen content

    • Decreased blood glucose concentrations

    • Elevated expression of appetite-stimulating agrp1 (agouti-related protein 1)

    • Increased expression of sla (somatolactin a) related to lipid catabolism

    These changes collectively indicate a state of energy deprivation and disrupted metabolic status despite accelerated growth.

  • Leptin signaling alterations:

    • Fluorescence in situ hybridization reveals leptin receptor expression in specific pituitary regions (pars intermedia and proximal pars distalis)

    • Recombinant carp Leptin protein stimulates pituitary gthα, fshβ, lhβ expression

    • Reduced hepatic leptin signaling to the pituitary contributes to delayed puberty onset

  • Glucose metabolism alterations:

    • GH-transgenic carp exhibit improved glucose tolerance test (GTT) performance

    • Plasma glucose concentration drops faster in transgenic carp (0.5-1 hour period)

    • Lower resting serum glucose concentration and hepatic glycogen content

    • Higher serum insulin levels compared to wild-type carp

This evidence suggests a metabolic trade-off mechanism where energy resources are prioritized for somatic growth at the expense of reproductive development, with leptin signaling playing a crucial intermediary role between metabolism and reproduction.

How does GH overexpression affect glucose metabolism in transgenic carp under varying dietary conditions?

GH overexpression significantly alters glucose metabolism in transgenic carp, with effects that vary depending on dietary carbohydrate content:

  • Baseline metabolic differences:

    • GH-transgenic carp exhibit lower serum glucose concentrations

    • Higher serum insulin levels compared to wild-type counterparts

    • Lower hepatic glycogen and pyruvate content

    • No significant difference in hepatic lactic acid content

  • Enhanced glucose tolerance:

    • During glucose tolerance tests (GTT), both transgenic and wild-type carp show increased plasma glucose concentrations peaking at 0.5 hours post-challenge

    • GH-transgenic carp demonstrate significantly faster glucose clearance rates during the critical 0.5-1 hour period

  • Response to high-carbohydrate diets:

    • When fed high-carbohydrate diets (40% carbohydrate), GH-transgenic carp maintain metabolic advantages

    • Transgenic fish maintain lower serum glucose levels despite high dietary carbohydrate intake

    • Researchers conclude that "overexpression of GH in common carp alleviated the adverse effects induced by a high-starch diet"

These findings suggest that GH overexpression confers metabolic resilience, enabling transgenic carp to more efficiently regulate glucose metabolism even under challenging dietary conditions. This research indicates potential molecular targets for improving carbohydrate utilization in aquaculture species, which typically have limited ability to metabolize dietary carbohydrates.

What developmental differences in intestinal morphology and function exist between GH-transgenic and wild-type carp?

GH overexpression induces significant developmental differences in intestinal morphology and function, which emerge at specific developmental timepoints:

  • Temporal intestinal development pattern:

    • No significant differences in intestinal weight between GH-transgenic and wild-type carp from 45 to 135 days post-fertilization (dpf)

    • At 165 dpf and beyond, transgenic carp develop significantly heavier intestines

    • Intestinal somatic index (ISI) remains similar between transgenic and wild-type fish throughout development

  • Region-specific intestinal adaptations:

    • Transgenic carp display distinct morphological and functional adaptations across different intestinal regions:

      • Foregut (0.3-0.5 cm before first fold)

      • Midgut (middle section of intestine)

      • Hindgut (0.3-0.5 cm after last fold)

  • Gene expression differences:

    • Expression levels of genes involved in nutrient transport differ between transgenic and wild-type carp

    • Peak expression typically occurs after 6-hour fasting (compared to 3, 12, or 24 hours)

These developmental differences provide critical insights into how GH overexpression enhances digestive efficiency and nutrient utilization, potentially contributing to the improved growth performance of transgenic carp. The region-specific approach to intestinal analysis demonstrates the importance of precise anatomical sampling in fish physiological research.

How should researchers interpret contradictory metabolic data when studying GH-transgenic carp?

When encountering apparently contradictory metabolic data in GH-transgenic carp research, investigators should employ several interpretive strategies:

  • Context-dependent hormone actions:

    • GH effects on metabolism are tissue-specific and context-dependent

    • Despite elevated serum GH levels, GH-transgenic carp show no differences in Igf1 and Igf2 levels compared to non-transgenics (P > 0.05)

    • Metabolic effects may depend on specific GH signaling pathways activated

  • Compensatory physiological mechanisms:

    • GH-transgenic carp show lower expression of endogenous pituitary GH despite transgene overexpression

    • Higher prolactin (Prl) levels in GH-transgenic carp suggest potential compensatory regulation

    • Unexpected metabolic findings may reflect homeostatic adaptations to chronic GH elevation

  • Methodological considerations:

    • Sampling timing significantly affects metabolic parameters:

      • Fasting duration affects gene expression peaks

      • Time points in glucose tolerance tests reveal different aspects of glucose metabolism

    • Statistical approach matters:

      • Use two-way ANOVA to determine interaction between GH levels and dietary treatments

      • Set appropriate significance thresholds (P < 0.05)

  • Developmental timeframe:

    • Some contradictions may be explained by developmental timing

    • Certain differences only emerge after specific developmental milestones (e.g., intestinal weight differences appearing only after 165 dpf)

By systematically considering these factors, researchers can resolve apparently contradictory data and develop more comprehensive models of how GH overexpression affects metabolism in transgenic carp.

What experimental feeding protocols effectively reveal metabolic differences between GH-transgenic and wild-type carp?

Researchers have developed specific experimental feeding protocols that effectively highlight metabolic differences between GH-transgenic and wild-type carp:

  • Dietary challenge design:

    • Normal-carbohydrate diet (30% carbohydrate, 33% protein, 6% fat)

    • High-carbohydrate diet (40% carbohydrate, 33% protein, 6% fat)

    • Maintaining consistent protein and fat content isolates carbohydrate metabolism effects

  • Feeding regime standardization:

    • Initial rearing on commercial aquafeed (33% protein, 6% fat, 22% carbohydrate)

    • Transfer to experimental diets at approximately 2 months of age

    • Consistent feeding frequency (typically twice daily)

  • Fasting protocols for specific measurements:

    • 6-hour fasting for gene expression and enzyme activity analyses

    • 48-hour fasting for morphological and histological studies

    • Overnight fasting for baseline metabolic parameters

    • Standardized fasting before glucose tolerance tests

  • Sampling strategy:

    • Age-matched sampling (both strains hatched on same day)

    • Specific intestinal regions (foregut, midgut, hindgut) sampled consistently

    • Timing of sampling standardized relative to last feeding

These protocol elements ensure that observed metabolic differences reflect true physiological variations rather than methodological inconsistencies, enhancing reproducibility and validity of research findings.

How should researchers design comprehensive gene expression studies for GH-transgenic carp?

Designing comprehensive gene expression studies for GH-transgenic carp requires careful consideration of several key methodological factors:

  • Target gene selection strategy:

    • Include genes from multiple functional categories:

      • Growth-related genes (gh, igf1, igf2)

      • Reproductive axis genes (gnrhr1-4, gthα, fshβ, lhβ, cyp19a1a, cyp19a1b)

      • Metabolic genes (gys, igfbp1)

      • Appetite regulation genes (agrp1, sla)

      • Neurotransmitter receptors (drd1, drd3, drd4)

  • Validation approach:

    • Initial RNA sequencing for genome-wide expression profiling

    • Targeted PCR confirmation of key differentially expressed genes

    • Semi-quantitative PCR for tissue-specific expression patterns

    • Western blotting for protein-level validation

  • Tissue sampling considerations:

    • Target tissues should include:

      • Hypothalamus (neuroendocrine regulation)

      • Pituitary (hormone production)

      • Gonads (reproductive development)

      • Liver (metabolic activity)

      • Intestinal segments (digestive function)

  • Temporal design elements:

    • Multiple developmental timepoints (45, 75, 105, 135, 165, 195 dpf)

    • Standardized sampling times relative to feeding/fasting

    • Consideration of circadian effects on gene expression

By implementing this comprehensive approach, researchers can identify both direct and indirect effects of GH overexpression on gene regulatory networks across multiple physiological systems.

What analytical techniques most effectively measure hormonal changes in GH-transgenic carp?

Several complementary analytical techniques provide comprehensive hormonal profiling in GH-transgenic carp:

  • Quantitative hormone measurement methods:

    • Enzyme-linked immunosorbent assay (ELISA):

      • Effective for measuring serum Gh, estradiol, Igf1, and Igf2 levels

      • Provides quantitative data suitable for statistical analysis

      • Results should be analyzed using appropriate statistical tests with significance typically set at P < 0.05

    • Western blotting:

      • Suitable for measuring pituitary hormone content

      • Can detect Gh, Lhβ, Gthα, and Prl protein levels

      • Provides semi-quantitative comparison between transgenic and wild-type fish

  • Receptor and signaling analysis techniques:

    • Fluorescence in situ hybridization:

      • Identifies receptor localization in specific tissues

      • Successfully used to detect leptin receptor in pituitary regions (pars intermedia and proximal pars distalis)

    • In vitro functional assays:

      • Recombinant protein stimulation tests

      • Assesses hormonal responses such as pituitary gthα, fshβ, lhβ expression

      • Evaluates functional endpoints like ovarian germinal vesicle breakdown

  • Metabolic hormone relationships:

    • Glucose tolerance tests with concurrent hormone sampling

    • Insulin level measurement in relation to glucose metabolism

    • Integration of hormonal data with metabolic parameters

These analytical approaches provide researchers with a powerful toolkit for comprehensively characterizing the complex hormonal changes in GH-transgenic carp, enabling mechanistic understanding of how GH overexpression affects multiple endocrine systems.

Product Science Overview

Introduction

Growth hormone carp recombinant refers to the genetically engineered growth hormone specifically designed for carp. This recombinant hormone is produced using advanced biotechnological techniques to enhance the growth rate and overall productivity of carp, a widely farmed fish species. The development of recombinant growth hormones for aquaculture aims to improve feed efficiency, growth performance, and overall sustainability of fish farming practices.

Development and Preparation

The development of recombinant growth hormone for carp involves the insertion of the growth hormone gene from carp into a suitable host organism, typically bacteria or yeast, which then produces the hormone in large quantities. The process includes several key steps:

  1. Gene Isolation: The growth hormone gene is isolated from carp using molecular biology techniques.
  2. Vector Construction: The isolated gene is inserted into a plasmid vector, which is a small circular DNA molecule used to transfer genetic material.
  3. Transformation: The plasmid vector containing the growth hormone gene is introduced into a host organism, such as Escherichia coli (E. coli) or yeast, through a process called transformation.
  4. Expression and Purification: The host organism expresses the growth hormone, which is then harvested and purified using various biochemical techniques to obtain the recombinant growth hormone.
Mechanism of Action

The recombinant growth hormone functions similarly to the natural growth hormone produced by carp. It binds to specific receptors on the surface of target cells, triggering a cascade of biochemical reactions that promote growth and development. The hormone stimulates protein synthesis, increases cell division, and enhances the utilization of nutrients, leading to improved growth rates and feed conversion efficiency in carp.

Applications in Aquaculture

The use of recombinant growth hormone in carp farming has several potential benefits:

  1. Enhanced Growth Rates: Carp treated with recombinant growth hormone exhibit significantly faster growth rates compared to untreated fish.
  2. Improved Feed Efficiency: The hormone enhances the ability of carp to convert feed into body mass, reducing the overall feed costs for farmers.
  3. Sustainability: By improving growth performance and feed efficiency, the use of recombinant growth hormone can contribute to more sustainable aquaculture practices, reducing the environmental impact of fish farming.
Safety and Regulatory Considerations

The use of recombinant growth hormone in aquaculture is subject to rigorous safety and regulatory assessments to ensure its safety for both the fish and consumers. Studies have shown that the recombinant growth hormone used in carp does not pose any significant risks to human health when consumed as part of the fish. Regulatory agencies evaluate the potential environmental impact, food safety, and ethical considerations before approving the use of recombinant growth hormones in aquaculture.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.